Sweet GRAS for “Bitter blocker”
This article was originally published in The Tan Sheet
FDA affirms adenosine monophosphate (AMP) - a natural compound that can be used to block the bitter taste of oral pharmaceuticals - as generally recognized as safe, Linguagen announces Sept. 15. AMP can "improve the taste" of products "without adding excess salt or sugar" and can be used in foods and beverages, Linguagen notes. The Cranbury, N.J.-based firm received a two-year, $746,000 NIH grant in 2002 to conduct research on AMP's ability to block the bitter taste signal pathway caused by pharmaceutical agents (1"The Tan Sheet" Oct. 7, 2002, p. 12)...
You may also be interested in...
NIH-funded research evaluating the efficacy of a bitter taste-inhibiting compound could result in the development of "more palatable" oral OTC drugs and subsequent improvements in patient compliance, according to grantee Linguagen Corp
Two European pharmaceutical companies, UCB and Merck KGaA, are exploring artificial intelligence in different ways, the first for drug discovery and the second on a fundamental level.
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.